Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-01 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
S | Common Stock | D | 2000 | $72.96 - $72.96 | $145,920 |
| 2024-03-10 | GILEAD SCIENCES, INC. | Telman Deborah H
(EVP, Corporate Affairs & GC) |
F | Common Stock | D | 846 | $75.12 - $75.12 | $63,551 |
| 2024-03-10 | GILEAD SCIENCES, INC. | Patterson Sandra
(SVP, Controllership) |
F | Common Stock | D | 790 | $75.12 - $75.12 | $59,344 |
| 2024-03-10 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
F | Common Stock | D | 4803 | $75.12 - $75.12 | $360,801 |
| 2024-03-10 | GILEAD SCIENCES, INC. | O'Day Daniel Patrick
(Chairman & CEO) |
F | Common Stock | D | 13782 | $75.12 - $75.12 | $1,035,303 |
| 2024-03-10 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
F | Common Stock | D | 4559 | $75.12 - $75.12 | $342,472 |
| 2024-03-10 | GILEAD SCIENCES, INC. | Dickinson Andrew D
(Chief Financial Officer) |
F | Common Stock | D | 4505 | $75.12 - $75.12 | $338,415 |
| 2024-02-28 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
S | Common Stock | D | 10230 | $72.74 - $73.18 | $744,983 |
| 2024-02-02 | GILEAD SCIENCES, INC. | LOVE TED W
(Director) |
A | Common Stock | A | 512 | $0.00 - $0.00 | $0 |
| 2024-01-31 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
F | Common Stock | D | 23709 | $78.26 - $78.26 | $1,855,466 |
| 2024-01-31 | GILEAD SCIENCES, INC. | Parsey Merdad
(Chief Medical Officer) |
A | Common Stock | A | 76853 | $0.00 - $0.00 | $0 |
| 2024-01-31 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
F | Common Stock | D | 22509 | $78.26 - $78.26 | $1,761,554 |
| 2024-01-31 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
A | Common Stock | A | 74055 | $0.00 - $0.00 | $0 |
| 2024-01-31 | GILEAD SCIENCES, INC. | Telman Deborah H
(EVP, Corporate Affairs & GC) |
A | Common Stock | A | 4646 | $0.00 - $0.00 | $0 |
| 2024-01-31 | GILEAD SCIENCES, INC. | O'Day Daniel Patrick
(Chairman & CEO) |
F | Common Stock | D | 79335 | $78.26 - $78.26 | $6,208,757 |
| 2024-01-31 | GILEAD SCIENCES, INC. | O'Day Daniel Patrick
(Chairman & CEO) |
A | Common Stock | A | 230747 | $0.00 - $0.00 | $0 |
| 2024-01-16 | GILEAD SCIENCES, INC. | Dickinson Andrew D
(Chief Financial Officer) |
S | Common Stock | D | 5000 | $85.78 - $85.78 | $428,900 |
| 2024-01-09 | GILEAD SCIENCES, INC. | Mercier Johanna
(Chief Commercial Officer) |
S | Common Stock | D | 8242 | $85.23 - $85.23 | $702,465 |
| 2023-11-10 | GILEAD SCIENCES, INC. | Dickinson Andrew D
(Chief Financial Officer) |
F | Common Stock | D | 804 | $75.92 - $75.92 | $61,039 |
| 2023-10-25 | GILEAD SCIENCES, INC. | Telman Deborah H
(EVP, Corporate Affairs & GC) |
F | Common Stock | D | 243 | $78.39 - $78.39 | $19,048 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |